Clinical Trial: Pediatric Disease Registry in Essential Thrombocythaemia (ET)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Multicentre Paediatric Disease Registry in Essential Thrombocythaemia

Brief Summary: The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.

Detailed Summary:
Sponsor: Shire

Current Primary Outcome: Treatment effects on platelet count in children ages 6-17 years inclusive. [ Time Frame: 60 months ]

Original Primary Outcome: To observe treatment effects on platelet count in children ages 6-17 years inclusive. [ Time Frame: 60 months ]

Current Secondary Outcome: Drug utilization of cytoreductive therapy in children ages 6-17 years inclusive [ Time Frame: 60 months ]

Original Secondary Outcome: To summarize drug utilization of cytoreductive therapy in children ages 6-17 years inclusive [ Time Frame: 60 months ]

Information By: Shire

Dates:
Date Received: September 8, 2010
Date Started: September 2010
Date Completion:
Last Updated: March 14, 2016
Last Verified: March 2016